© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Daclatasvir dihydrochloride comes into play as a vital raw material in the world of pharmaceutical chemistry, standing as the backbone for hepatitis C antiviral therapy. Sitting in its pure form, daclatasvir dihydrochloride appears as a white to off-white crystalline powder. It rarely takes on moisture from the air, but store it right and you won’t run into any trouble with degradation. This chemical doesn’t release any strong odor. It shows itself as flakes, powder, or crystals depending on how it is processed, and its touch and flow give away a clue to its use in pill or syringe formulations. You can pack it or ship it as solid bulk, sealed from outside air to keep its physical characteristics undisturbed.
Daclatasvir dihydrochloride bears the molecular formula C40H52Cl2N8O6, with a molecular weight close to 811.81 g/mol. Breaking down its structure, it presents as a complex organic molecule with several aromatic rings, a handful of nitrogen atoms, and two hydrochloride groups attached, which aid solubility and stability in storage and formulation. The chemical has a melting point around 280°C to 285°C, keeping it stable even above room temperature. The powder’s density comes in around 1.28 g/cm³, which affects how manufacturers measure and mix it for drugs. That dense structure works well in solid forms, so companies can shape it into tablets or blend it into ready-to-use pharmaceutical solutions.
Looking at bulk daclatasvir dihydrochloride, its particle size lies in the micrometer range, crucial for blending evenly in medication batches. The fine powder spreads evenly on mixing trays. What stands out is its relatively good solubility in water and ethanol, making it easy for formulation scientists to dissolve in different solutions during manufacturing. Unlike many chemicals that release harmful gases, daclatasvir dihydrochloride holds steady without breaking down or forming vapors at room temperature or under light. A sample left exposed won’t clump quickly unless soaked with moisture, highlighting its robustness as a pharmaceutical ingredient.
For customs and regulatory purposes, daclatasvir dihydrochloride typically goes under HS Code 2934999099, categorizing it as an organic compound used in medicine. Border agents and logistics coordinators recognize this code, giving manufacturers confidence that their shipments won’t get flagged as hazardous or suspicious. The correct coding streamlines global supply, simplifies documentation, and helps comply with import-export regulations.
Anyone who spends time around chemical synthesis labs knows the need for sharp focus on safe handling. Daclatasvir dihydrochloride does not show acute toxicity at the levels used in research, but inhaling its dust or letting it settle on bare skin always carries risk. Wearing gloves, masks, and goggles shouldn’t just be protocol—it’s practical, hands-on safety. Though not known for explosive or highly flammable qualities, basic chemical hygiene saves needless headaches. Label containers clearly, store sealed sachets in cool, dry spaces, and keep information sheets handy in the lab for anyone double-checking property or hazard data. The substance classifies as a non-hazardous chemical for transport, so it does not require aggressive hazard warnings in most jurisdictions. Clean spills with damp disposable cloths instead of dry sweeping, which could kick up dust. Dispose of waste with the same discipline reserved for all pharmaceutical precursors, complying with both local regulations and company guidelines.
Daclatasvir dihydrochloride matters most as a central raw material for antiviral treatment. It helps push hepatitis C toward eradication, working as one arm of a duo or trio in direct-acting antiviral therapies. Because of the compound’s structure and physical properties, production teams count on reliable composition, purity, and ease of blending with other actives. Patients benefit because upstream attention to these physical and chemical assets leads to higher therapeutic success rates and fewer side effects. Beyond its direct action, daclatasvir dihydrochloride signals a shift away from broad-acting, sometimes harsh, treatments toward more targeted, tolerable drugs. That motivates both chemists and public health advocates, since the chance of moving vulnerable populations off protracted illness depends on materials like this delivering on stability, purity, and safety.
Supply chain stability always shadows the pharmaceutical world. When sourcing raw chemicals like daclatasvir dihydrochloride, purity can wander if suppliers cut corners. Batches that don’t meet specified density, particle size, or melting range put the entire downstream process at risk. The right solution starts at the supplier’s doorstep: audit trails, full certificates of analysis, and chemical authentication. This helps prevent counterfeits or contamination that could slip into finished drugs. Everyone in the chain—from bulk material handlers to research pharmacists—should have regular training, ensuring they spot any subtle change in the look or texture of the chemical. Swapping information between labs about lot quality or formulation quirks helps, too.
Daclatasvir dihydrochloride holds its place as a high-purity, non-volatile, stable white crystalline powder, supporting breakthrough hepatitis C therapies. With a sturdy molecular formula, important density and solubility properties, and a clear safety profile in the lab, it simplifies both storage and shipping under defined HS Codes. Those charged with its handling should trust in robust protective gear and tight container management, treating each lot with care to preserve the integrity of finished pharmaceutical products. Pharmaceuticals built on quality chemicals lead to direct improvements in patient health, public safety, and the trust placed in medicine worldwide.
